Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritis

Authors :: Kevin Y. C. Su
Veera Srividya Katikireddi
Lisa Cummins
Ranjeny Thomas
Sateesh Shankaranarayana
Helen Pahau
Emily Duggan
Vibeke Videm
Source :: Internal Medicine Journal. 45:1266-1273
Publication Year :: 2015
Publisher :: Wiley, 2015.
Abstract: BackgroundWhile efficacy of combination treatment with methotrexate (MTX), sulfasalazine (SSZ) and hydroxychloroquine (HCQ) (triple therapy') has been shown in clinical trials, few studies have examined its longevity in a real-life setting.

Subjects :: medicine.medical_specialty
business.industry
Hydroxychloroquine
medicine.disease
Gastroenterology
Surgery
Clinical trial
Antirheumatic Agents
Sulfasalazine
Internal medicine
Rheumatoid arthritis
Medication Persistence
Internal Medicine
medicine
Methotrexate
Prospective cohort study
business
medicine.drug

Full Text Access

Tools